Clinical Trials Browser

Phase 1 × selitrectinib × Tumor-Agnostic × Clear all

NCT03215511 2024-10-30

A Study to Test the Safety of the Investigational Drug Selitrectinib in Children and Adults That May Treat Cancer

Phase 1 Completed

Neoplasm Metastasis